These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33388643)

  • 21. Enantiomeric separation of bupropion enantiomers by electrokinetic chromatography: quantitative analysis in pharmaceutical formulations.
    Castro-Puyana M; García MA; Marina ML
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):260-5. PubMed ID: 18823826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependency of flurbiprofen enantiomer pharmacokinetics in the rat.
    Jamali F; Berry BW; Wright MR
    J Pharm Sci; 1994 Aug; 83(8):1077-80. PubMed ID: 7983589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.
    Lin JH; Lin TH; Cheng H
    Pharm Res; 1992 Mar; 9(3):339-44. PubMed ID: 1614967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of the active antifungal enantiomer, SCH 42427 (RR), and evaluation of its chiral inversion in animals following its oral administration and the oral administration of its racemate genaconazole (RR/SS).
    Kim H; Radwanski E; Lovey R; Lin CC; Nomeir AA
    Chirality; 2002 May; 14(5):436-41. PubMed ID: 11984759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography.
    Suckow RF; Zhang MF; Cooper TB
    Biomed Chromatogr; 1997; 11(3):174-9. PubMed ID: 9192113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats.
    Zhu CJ; Zhang JT
    Chirality; 2009 Mar; 21(3):402-6. PubMed ID: 18655159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioanalysis of chiral compounds during drug development using a tiered approach.
    Jian W; Edom RW; Huang MQ; Weng N
    Bioanalysis; 2014 Mar; 6(5):629-39. PubMed ID: 24620805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Rat Plasma and Brain Extracellular Fluid Pharmacokinetic Model for Bupropion and Hydroxybupropion Based on Microdialysis Sampling, and Application to Predict Human Brain Concentrations.
    Cremers TI; Flik G; Folgering JH; Rollema H; Stratford RE
    Drug Metab Dispos; 2016 May; 44(5):624-33. PubMed ID: 26916207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective pharmacokinetics of flobufen in rats.
    Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
    Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats.
    Meunier CJ; Verbeeck RK
    Pharm Res; 1999 Jul; 16(7):1081-6. PubMed ID: 10450934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chiral inversion of 2-arylpropionoic acid (2-APA) enantiomers during simulated biological wastewater treatment.
    Nguyen AQ; Nguyen LN; McDonald JA; Nghiem LD; Leusch FDL; Neale PA; Khan SJ
    Water Res; 2022 Feb; 209():117871. PubMed ID: 34872028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats.
    Yoshida H; Kohno Y; Endo H; Yamaguchi J; Fukushima K; Suwa T; Hayashi M
    Biochem Pharmacol; 1997 Jan; 53(2):179-87. PubMed ID: 9037250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats.
    Kuo BS; Poole JC; Mandagere AK; Hwang KK
    Chirality; 1993; 5(6):428-35. PubMed ID: 8398602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of doxazosin enantiomers in rat plasma and investigation of their chiral inversion].
    Zhen YQ; Kong DZ; Li Q; Zhao J; Ren LM
    Yao Xue Xue Bao; 2013 Jun; 48(6):901-5. PubMed ID: 23984526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the metabolic chiral inversion of D-leucine in rat by gas chromatography-mass spectrometry combined with a stable isotope dilution analysis.
    Hasegawa H; Matsukawa T; Shinohara Y; Hashimoto T
    Drug Metab Dispos; 2000 Aug; 28(8):920-4. PubMed ID: 10901701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
    Haegele KD; Schechter PJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interspecies differences in stereoselective protein binding and clearance of MK-571.
    Tocco DJ; deLuna FA; Duncan AE; Hsieh JH; Lin JH
    Drug Metab Dispos; 1990; 18(4):388-92. PubMed ID: 1976057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chirality and pharmacokinetics: an area of neglected dimensionality?
    Hutt AJ
    Drug Metabol Drug Interact; 2007; 22(2-3):79-112. PubMed ID: 17708062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.